sion-719
sion-719: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Sionna Therapeutics, Inc. (SION) | Phase 2 |
Clinical Trials (1)
A Phase 2a Randomized, Double-blind, Placebo-controlled Proof-of-concept Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of SION-719 When Added to Physician-prescribed Trikafta® in People With Cystic Fibrosis Who Are Homozygous for the F508del Mutation
Frequently asked questions
Who is developing sion-719?
sion-719 is being developed by Sionna Therapeutics, Inc..
How many clinical trials involve sion-719?
BioSniper tracks 1 clinical trial involving sion-719.
Get deeper analysis on sion-719
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis